Epidermal Growth Factor Receptor , c-MET ,-Catenin , and p 53 Expression as Prognostic Indicators in Stage II Colon Cancer : A Tissue Microarray Study

Purpose: Through the use of molecular markers, it may be possible to identify aggressive tumor phenotypes and tailor therapies to treat them. This approach would be particularly useful for stage II colon cancer. The purpose of this study was to define the prognostic value of epidermal growth factor receptor (EGFR), c-MET, -catenin, and p53 protein… (More)